- £5.30bn
- £6.27bn
- $2.14bn
- 68
- 18
- 89
- 62
REG - ConvaTec Group PLC - Annual Report and Accounts 2021 and Notice of AGM
AnnouncementREG - ConvaTec Group PLC - Director/PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Director/PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Director/PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Board Change
AnnouncementREG - ConvaTec Group PLC - Acquisition Completion of Triad Life Sciences Inc
AnnouncementREG - ConvaTec Group PLC - Annual Results
AnnouncementREG - ConvaTec Group PLC - Non-Executive Director Changes
AnnouncementREG - ConvaTec Group PLC abrdn PLC - Holding(s) in Company
AnnouncementREG - ConvaTec Group PLC - Acquisition: entry into attractive wound biologics
AnnouncementREG - ConvaTec Group PLC - Board Committee Changes
AnnouncementREG - ConvaTec Group PLC - Block Listing Application
AnnouncementREG - ConvaTec Group PLC - Non-Executive Director appointment
AnnouncementREG - ConvaTec Group PLC - Chief Financial Officer succession
AnnouncementREG - ConvaTec Group PLC - Total Voting Rights
AnnouncementREG - ConvaTec Group PLC - Q3 Trading Update
AnnouncementREG - ConvaTec Group PLC - Director/PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Pricing of $500M 3.875% Senior Notes due 2029
AnnouncementREG - ConvaTec Group PLC - ConvaTec Announces Offer of $500M Senior Notes
Announcement